Hays and her husband who have a Medicare Part D drug plan. As a result, she expects to shell out a lot less at the pharmacy counter in 2025.   “That $2,000 cap,” which will be adjusted annually for ...

GoodRx CEO Wendy Barnes outlined the company's priorities at the 2025 JP Morgan Healthcare Conference in San Francisco.

The AARP report suggests the spending cap could be huge for Medicare enrollees who take costly drugs for cancer, rheumatoid ...

Rising drug prices don't have to break your budget. GoodRx's free service can help you find the best deals on prescriptions ...

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

Leerink Partners analyst Michael Cherny has maintained their bullish stance on GDRX stock, giving a Buy rating on January 10.Stay Ahead of the ...

GoodRx Holdings, Inc. (NASDAQ:GDRX – Get Free Report) dropped 8.4% during trading on Monday after Citigroup lowered their price target on the stock from $7.00 to $6.25. Citigroup currently has a buy ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...

Pet owners now have a new online resource that can help them save money. GoodRx, a company known for offering consumers ...

Cigna (CI) and UnitedHealth (UNH) significantly marked up prices for specialty generic drugs over a six-year period.

GoodRx (NASDAQ:GDRX – Free Report) had its price objective reduced by Citigroup from $7.00 to $6.25 in a research note issued ...